Compare with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN PHARMACEUTICALS vs ALEMBIC PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN PHARMACEUTICALS ALEMBIC PHARMA SUVEN PHARMACEUTICALS/
ALEMBIC PHARMA
 
P/E (TTM) x 40.8 18.4 222.0% View Chart
P/BV x 11.2 2.9 386.5% View Chart
Dividend Yield % 0.4 1.9 20.8%  

Financials

 SUVEN PHARMACEUTICALS   ALEMBIC PHARMA
EQUITY SHARE DATA
    SUVEN PHARMACEUTICALS
Mar-21
ALEMBIC PHARMA
Mar-21
SUVEN PHARMACEUTICALS/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs5251,150 45.7%   
Low Rs103527 19.5%   
Sales per share (Unadj.) Rs39.7274.4 14.5%  
Earnings per share (Unadj.) Rs12.156.7 21.4%  
Cash flow per share (Unadj.) Rs13.466.0 20.2%  
Dividends per share (Unadj.) Rs2.0014.00 14.3%  
Avg Dividend yield %0.61.7 38.1%  
Book value per share (Unadj.) Rs46.4260.9 17.8%  
Shares outstanding (eoy) m254.57196.56 129.5%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x7.93.1 259.1%   
Avg P/E ratio x25.914.8 175.2%  
P/CF ratio (eoy) x23.512.7 185.1%  
Price / Book Value ratio x6.83.2 210.7%  
Dividend payout %16.524.7 66.8%   
Avg Mkt Cap Rs m79,953164,818 48.5%   
No. of employees `000NANA-   
Total wages/salary Rs m76210,512 7.3%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m10,09753,931 18.7%  
Other income Rs m142875 16.3%   
Total revenues Rs m10,24054,806 18.7%   
Gross profit Rs m4,43014,801 29.9%  
Depreciation Rs m3161,835 17.2%   
Interest Rs m117160 72.8%   
Profit before tax Rs m4,13913,681 30.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,0532,533 41.6%   
Profit after tax Rs m3,08611,148 27.7%  
Gross profit margin %43.927.4 159.9%  
Effective tax rate %25.418.5 137.4%   
Net profit margin %30.620.7 147.9%  
BALANCE SHEET DATA
Current assets Rs m6,66525,779 25.9%   
Current liabilities Rs m3,21512,808 25.1%   
Net working cap to sales %34.224.1 142.1%  
Current ratio x2.12.0 103.0%  
Inventory Days Days20023 850.7%  
Debtors Days Days37024 1,568.8%  
Net fixed assets Rs m9,09741,311 22.0%   
Share capital Rs m255393 64.8%   
"Free" reserves Rs m11,55450,883 22.7%   
Net worth Rs m11,80851,276 23.0%   
Long term debt Rs m3561,999 17.8%   
Total assets Rs m15,76267,090 23.5%  
Interest coverage x36.586.4 42.2%   
Debt to equity ratio x00 77.3%  
Sales to assets ratio x0.60.8 79.7%   
Return on assets %20.316.9 120.6%  
Return on equity %26.121.7 120.2%  
Return on capital %35.026.0 134.7%  
Exports to sales %066.8 0.0%   
Imports to sales %012.7 0.0%   
Exports (fob) Rs mNA36,020 0.0%   
Imports (cif) Rs mNA6,845 0.0%   
Fx inflow Rs m9,90236,020 27.5%   
Fx outflow Rs m1,3696,845 20.0%   
Net fx Rs m8,53329,175 29.2%   
CASH FLOW
From Operations Rs m3,83414,634 26.2%  
From Investments Rs m-3,114-8,388 37.1%  
From Financial Activity Rs m-766-5,974 12.8%  
Net Cashflow Rs m-45262 -17.2%  

Share Holding

Indian Promoters % 60.0 69.0 87.0%  
Foreign collaborators % 0.0 0.5 -  
Indian inst/Mut Fund % 14.2 17.5 81.0%  
FIIs % 8.3 5.9 140.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 40.0 30.5 131.1%  
Shareholders   86,447 110,038 78.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN PHARMACEUTICALS With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

Sensex Tanks 650 Points Tracking Weak Global Cues, Nifty Below 17,450; Metal & IT Stocks Bleed(10:30 am)

Asian stock markets are lower today on expectations that the Fed will soon start draining the massive liquidity that has fueled the huge gains in growth stocks in recent years.

Related Views on News

SUVEN PHARMACEUTICALS 2020-21 Annual Report Analysis (Annual Result Update)

Sep 6, 2021 | Updated on Sep 6, 2021

Here's an analysis of the annual report of SUVEN PHARMACEUTICALS for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SUVEN PHARMACEUTICALS. Also includes updates on the valuation of SUVEN PHARMACEUTICALS.

ALEMBIC PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Jul 8, 2021 | Updated on Jul 8, 2021

Here's an analysis of the annual report of ALEMBIC PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

More Views on News

Most Popular

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN PHARMACEUTICALS SHARE PRICE


Jan 24, 2022 12:47 PM

TRACK SUVEN PHARMACEUTICALS

  • Track your investment in SUVEN PHARMACEUTICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS 8-QTR ANALYSIS

COMPARE SUVEN PHARMACEUTICALS WITH

MARKET STATS